Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

BioProgress to inlicense MuGard

Feb. 12, 2007

ABT-737 shows antimyeloma activity alone or in combination in preclinical studies

Feb. 12, 2007

Financing at Proacta to support development of PR-104

Feb. 12, 2007

CD24 and BAG-1 suggested as prognostic markers for aggressive breast cancer

Feb. 12, 2007

CHK1 drug discovery program advances

Feb. 12, 2007

Enrollment completed in safety study of EOquin in noninvasive bladder cancer

Feb. 12, 2007

Sutent approved with new data for advanced renal cell carcinoma

Feb. 9, 2007

Japanese study supports further evaluation of hypertension chemotherapy

Feb. 9, 2007

Kallikrein 6 studied as a prognostic marker and a therapeutic target in ovarian cancer

Feb. 9, 2007

Seliciclib to be investigated for nasopharyngeal cancer

Feb. 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...